- Home
- SLI vs TMCI Comparison
SLI vs TMCI Comparison
Compare SLI & TMCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLI
- TMCI
- Stock Information
- Founded
- SLI 1998
- TMCI 2014
- Country
- SLI Canada
- TMCI United States
- Employees
- SLI N/A
- TMCI N/A
- Industry
- SLI Major Chemicals
- TMCI Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- SLI Industrials
- TMCI Health Care
- Exchange
- SLI Nasdaq
- TMCI Nasdaq
- Market Cap
- SLI 406.1M
- TMCI 329.0M
- IPO Year
- SLI N/A
- TMCI 2021
- Fundamental
- Price
- SLI $1.72
- TMCI $7.83
- Analyst Decision
- SLI Strong Buy
- TMCI Hold
- Analyst Count
- SLI 1
- TMCI 6
- Target Price
- SLI $3.50
- TMCI $7.40
- AVG Volume (30 Days)
- SLI 2.2M
- TMCI 780.3K
- Earning Date
- SLI 11-12-2024
- TMCI 11-05-2024
- Dividend Yield
- SLI N/A
- TMCI N/A
- EPS Growth
- SLI N/A
- TMCI N/A
- EPS
- SLI 0.61
- TMCI N/A
- Revenue
- SLI N/A
- TMCI $202,861,000.00
- Revenue This Year
- SLI N/A
- TMCI $13.15
- Revenue Next Year
- SLI N/A
- TMCI $8.36
- P/E Ratio
- SLI $2.92
- TMCI N/A
- Revenue Growth
- SLI N/A
- TMCI 16.14
- 52 Week Low
- SLI $1.05
- TMCI $3.92
- 52 Week High
- SLI $2.64
- TMCI $15.98
- Technical
- Relative Strength Index (RSI)
- SLI 41.54
- TMCI 66.72
- Support Level
- SLI $1.60
- TMCI $7.21
- Resistance Level
- SLI $1.82
- TMCI $8.06
- Average True Range (ATR)
- SLI 0.16
- TMCI 0.45
- MACD
- SLI -0.07
- TMCI 0.04
- Stochastic Oscillator
- SLI 18.59
- TMCI 82.14
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, Tetra Project, and Bristol Dry Lake Project.
About TMCI Treace Medical Concepts Inc.
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The Company operates and manages its business as one segment, which is the business of designing, manufacturing, and marketing medical devices for physicians, surgeons, ambulatory surgery centers, and hospitals.